| Metric | H1 FY26 | H2 FY25 | H1 FY25 |
|---|---|---|---|
| Other income | 0.3 | 0.3 | 0.3 |
| Total income | 58.6 | 48.3 | 44.7 |
| Net profit | 6.6 | 1.3 | 3.5 |
| Operating margin | 15.0% | 3.7% | 10.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +88.60% |
|---|---|
| Net profit, quarter on quarter | +407.70% |
BSE results filing, NSE: SAAKSHI. Figures extracted from the filing.
Saakshi Medtech & Panels Ltd: key numbers
- Share price
- ₹367.00
- Market cap
- ₹721.8 Cr
- Revenue (annual)
- ₹115.5 Cr
- Net profit (annual)
- ₹12.29 Cr
- P/E (TTM)
- 58.7×Sector 55.4×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saakshi Medtech & Panels Ltd
All →Saakshi Medtech & Panels Management Change
Saakshi Medtech and Panels Limited issued a revised disclosure regarding the appointment of Mr. Nandkumar Vasant Dhekne as Independent Director and Mr. Ravi Madhav Vartak as Whole-time Director.
Saakshi Medtech & Panels Capital Structure Change
Saakshi Medtech and Panels Limited received NSE's in-principle approval to list 2,010,259 equity shares of ₹10 each issued via preferential allotment.
Saakshi Medtech & Panels Annual General Meeting
Saakshi Medtech and Panels Limited has scheduled its 17th Annual General Meeting for September 30, 2026. Shareholders will consider financial statements and director appointments.
Saakshi Medtech & Panels Board Meeting Outcome
Saakshi Medtech and Panels Limited announced the re-appointment of Mr. Aniket Latkar as Chairman and Managing Director for a five-year term, effective June 8, 2026.
- Execution
- 5 years
Saakshi Medtech & Panels Capital Structure Change
Saakshi Medtech and Panels Limited approved the preferential allotment of 2,010,259 equity shares at Rs. 207 per share, aggregating to Rs. 41.61 Crore.
- Value
- ₹41.61 Cr
Saakshi Medtech & Panels Capital Structure Change
Saakshi Medtech received in-principle approval from NSE for a preferential issue of 20,22,940 equity shares. The shares are priced at Rs. 207 each via share swap.
- Value
- ₹41.87 Cr